Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DAWN
DataOraFonteTitoloSimboloCompagnia
06/03/202523:02Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:DAWNDay One Biopharmaceuticals Inc
01/03/202501:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
25/02/202522:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DAWNDay One Biopharmaceuticals Inc
22/02/202500:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
19/02/202500:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
13/01/202514:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/01/202522:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/08/202422:07Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:DAWNDay One Biopharmaceuticals Inc
05/08/202423:05Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202315:54Dow Jones NewsDay One Biopharmaceuticals Shares Rally on FDA Priority ReviewNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/10/202313:58Dow Jones NewsDay One Gets FDA Priority Review of Tovorafenib in Pediatric Brain TumorNASDAQ:DAWNDay One Biopharmaceuticals Inc
20/10/202322:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DAWNDay One Biopharmaceuticals Inc
27/06/202301:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DAWNDay One Biopharmaceuticals Inc
23/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/06/202322:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/06/202313:00PR Newswire (US)KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMANASDAQ:DAWNDay One Biopharmaceuticals Inc
07/06/202322:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
05/06/202322:50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:DAWNDay One Biopharmaceuticals Inc
01/05/202315:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DAWNDay One Biopharmaceuticals Inc
28/04/202322:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202322:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/02/202300:21Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:DAWNDay One Biopharmaceuticals Inc
09/01/202319:16Dow Jones NewsDay One Biopharma Shares Rise 13% After Positive Topline Results for TovorafenibNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/11/202213:15TipRanksJ.P. Morgan Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
08/11/202214:55TipRanksJonesTrading Reaffirms Their Buy Rating on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
31/10/202221:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DAWNDay One Biopharmaceuticals Inc
14/09/202217:05TipRanksJonesTrading Remains a Buy on Day One Biopharmaceuticals (DAWN)NASDAQ:DAWNDay One Biopharmaceuticals Inc
12/09/202217:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DAWNDay One Biopharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DAWN